Patents by Inventor Satheesh RAVULA

Satheesh RAVULA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemoembolization agents
    Patent number: 12357570
    Abstract: Described herein is a chemoembolization therapy, which combines therapeutic effects of peripheral arterial occlusion with the local administration of an anti-cancer agent. A particle or microsphere occludes the arteries providing blood flow to the tumor, resulting in tumor oxygen deprivation. The anti-angiogenic agent is an anti-cancer drug, as described herein.
    Type: Grant
    Filed: June 19, 2023
    Date of Patent: July 15, 2025
    Assignees: BRUIN BIOSCIENCES, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: James Na, David Imagawa, Fabio Tucci, Graham Beaton, Satheesh Ravula
  • Pyrimidine and pyridine amine compounds and usage thereof in disease treatment
    Patent number: 12234224
    Abstract: Pyrimidine and Pyridine containing compounds are described herein that are enzyme p70S6K inhibitors useful in the treatment of S6K-dependent or S6K-mediated diseases and conditions, including but not limited to cancer, fibrotic metabolic and certain neurological disorders.
    Type: Grant
    Filed: December 6, 2023
    Date of Patent: February 25, 2025
    Assignee: EPIGEN Biosciences, Inc.
    Inventors: Graham Beaton, Fabio Tucci, Satheesh Ravula, Suk Joong Lee, Chandravadan Shah
  • PYRIMIDINE AND PYRIDINE AMINE COMPOUNDS AND USAGE THEREOF IN DISEASE TREATMENT
    Publication number: 20240124423
    Abstract: Pyrimidine and Pyridine containing compounds are described herein that are enzyme p70S6K inhibitors useful in the treatment of S6K-dependent or S6K-mediated diseases and conditions, including but not limited to cancer, fibrotic metabolic and certain neurological disorders.
    Type: Application
    Filed: December 6, 2023
    Publication date: April 18, 2024
    Applicant: Epigen Biosciences, Inc.
    Inventors: Graham Beaton, Fabio Tucci, Satheesh Ravula, Suk Joong Lee, Chandravadan Shah
  • Pyrimidine and pyridine amine compounds and usage thereof in disease treatment
    Patent number: 11866421
    Abstract: Pyrimidine and Pyridine containing compounds are described herein that are enzyme p70S6K inhibitors useful in the treatment of S6K-dependent or S6K-mediated diseases and conditions, including but not limited to cancer, fibrotic metabolic and certain neurological disorders.
    Type: Grant
    Filed: May 31, 2021
    Date of Patent: January 9, 2024
    Assignee: Epigen Biosciences, INC.
    Inventors: Graham Beaton, Fabio Tucci, Satheesh Ravula, Suk Joong Lee, Chandravadan Shah
  • CHEMOEMBOLIZATION AGENTS
    Publication number: 20230346701
    Abstract: Described herein is a chemoembolization therapy, which combines therapeutic effects of peripheral arterial occlusion with the local administration of an anti-cancer agent. A particle or microsphere occludes the arteries providing blood flow to the tumor, resulting in tumor oxygen deprivation. The anti-angiogenic agent is an anti-cancer drug, as described herein.
    Type: Application
    Filed: June 19, 2023
    Publication date: November 2, 2023
    Applicants: BRUIN BIOSCIENCES, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: James NA, David IMAGAWA, Fabio TUCCI, Graham BEATON, Satheesh RAVULA
  • Chemoembolization agents
    Patent number: 11712418
    Abstract: A chemoembolization therapy, which combines therapeutic effects of peripheral arterial occlusion with the local administration of an anti-cancer agent. A particle or microsphere occludes the arteries providing blood flow to the tumor, resulting in tumor oxygen deprivation. The anti-angiogenic agent is an anti-cancer drug.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: August 1, 2023
    Assignees: BRUIN BIOSCIENCES, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: James Na, David Imagawa, Fabio Tucci, Graham Beaton, Satheesh Ravula
  • PYRIMIDINE AND PYRIDINE AMINE COMPOUNDS AND USAGE THEREOF IN DISEASE TREATMENT
    Publication number: 20220396564
    Abstract: Pyrimidine and Pyridine containing compounds are described herein that are enzyme p70S6K inhibitors useful in the treatment of S6K-dependent or S6K-mediated diseases and conditions, including but not limited to cancer, fibrotic metabolic and certain neurological disorders.
    Type: Application
    Filed: May 31, 2021
    Publication date: December 15, 2022
    Applicant: Epigen Biosciences, Inc.
    Inventors: Graham Beaton, Fabio Tucci, Satheesh Ravula, Suk Joong Lee, Chandravadan Shah
  • CHEMOEMBOLIZATION AGENTS
    Publication number: 20210169801
    Abstract: A chemoembolization therapy, which combines therapeutic effects of peripheral arterial occlusion with the local administration of an anti-cancer agent. A particle or microsphere occludes the arteries providing blood flow to the tumor, resulting in tumor oxygen deprivation. The anti-angiogenic agent is an anti-cancer drug.
    Type: Application
    Filed: May 25, 2018
    Publication date: June 10, 2021
    Applicants: BRUIN BIOSCIENCES, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: James NA, David IMAGAWA, Fabio TUCCI, Graham BEATON, Satheesh RAVULA